Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)

PHASE4CompletedINTERVENTIONAL
Enrollment

519

Participants

Timeline

Start Date

November 11, 2018

Primary Completion Date

January 20, 2022

Study Completion Date

May 16, 2022

Conditions
Acute Decompensated Heart FailureVolume Overload
Interventions
DRUG

Acetazolamide

In the experimental group, the patient will receive the standard of care loop diuretics and acetazolamide

DRUG

Placebo

In the placebo group, the patient will receive the standard of care loop diuretics and the placebo

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg AV, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER

NCT03505788 - Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR) | Biotech Hunter | Biotech Hunter